KRIS anbefaler omstridt kræftmiddel
Relaterede artikler
Omstridt kræftmiddel tæt på udvidet godkendelse
For abonnenter
KRIS åbner op
For abonnenter
En del af Watch Medier
For abonnenter
For abonnenter
Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.
NyhedsbrevsvilkårFor abonnenter
For abonnenter
For abonnenter
QA/RA Specialist, Patient Handling Division
Quality Engineer for Production
Principal Quality Assurance Professional – Combination Products
QP delegate Biologics, CMC
Senior Legal Counsel
Skilled Process Specialist for managing logistic and production processes in SAP
QA Manager GMP
Global Head of Rewards
Material Scientist and Coordinator
Produktionskemiker
Environmental Monitoring Professional
ESG Officer
Principal Bioinformatic Scientist, Antibody Technology
Healthcare Compliance Senior Specialist (Associated Director), Ascendis Pharma
Investor Relations Manager
Principal Research Scientist within Biophysical characterisation and pre-formulation
Senior Consultant / Project Manager - Life Science (R&D & Clinical)
Head of OTC Product Development
Governmental Public Affairs & Communications Head
Senior Laboratory Technician (Laborant) – Biophysical Protein Characterization
Head of Quality Assurance
Business Development Manager